Abstract:Background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been reported to be associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. However, the understanding of its regulatory role in the carcinogenesis of Head And Neck Squamous Cell Carcinoma (HNSC) is limited. background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. Methods: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using The Cancer Genome Atlas (TCGA) database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T lentivirus. The xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. objective: To study the understanding of its regulatory role in the carcinogenesis of head and neck squamous cell carcinoma (HNSC). Results: The increased expression of UBE2T was noted in tumor tissues of patients with HNSC, correlating with a significantly reduced overall survival time in this patient cohort. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling and induced ferroptosis in HNSC. method: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using TCGA database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T-derived lentivirus. Cell line-derived xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. Conclusion: Our study underscores the multifaceted role of UBE2T in HNSC, illuminating its potential as a biomarker and therapeutic target. result: High expression of UBE2T were consistently observed in HNSC tumor tissues, which correlated with a significantly shortened overall survival time among HNSC patients. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling activation and induced ferroptosis in HNSC.

UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination

METTL3 Regulates the Malignancy of Cervical Cancer Via Post-Transcriptional Regulation of RAB2B

The High NRF2 Expression Confers Chemotherapy Resistance Partly Through Up-Regulated DUSP1 in Myelodysplastic Syndromes

NUF2 Drives Cholangiocarcinoma Progression and Migration Via Inhibiting Autophagic Degradation of TFR1

The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5

UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF‐κB signaling by increasing IκBα degradation

UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma

CNN3 Acts As a Potential Oncogene in Cervical Cancer by Affecting RPLP1 Mrna Expression

uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells

Uch-L1 Involved in Regulating the Degradation of Egfr and Promoting Malignant Properties in Drug-Resistant Breast Cancer

The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein

Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression

UCHL1 promotes cancer stemness in triple-negative breast cancer

Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis

UCHL1 is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance

METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21

CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression

NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma